Turn Therapeutics, Inc. (NASDAQ: TTRX), a clinical-stage biotechnology company developing targeted, non-systemic therapies for inflammatory skin diseases, today announced it will host a live webcast ...
Research rethinks amino acid origins, revealing insights into life’s earliest building blocks on Earth and potential clues ...
The parent of bankESB and TruNorth Bank will end its 157-year history as a depositor-owned institution, in part to fund the ...
Imagion has strengthened its partnership with Siemens for the next stage of clinical testing on its MagSense cancer imaging ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results